Blue Water Acquisition Corp. (46)

Browse by Contract Category

Contracts

Registration Rights Agreement, dated as of December 3, 2021, among Clarus Therapeutics Holdings, Inc. and each purchaser party thereto (Filed With SEC on December 7, 2021)
Clarus Therapeutics Holdings, Inc. 2021 Stock Option and Incentive Plan (Filed With SEC on September 30, 2021)
Form of Indemnification Agreement (Directors) (Filed With SEC on September 15, 2021)
Description of Registered Securities (Filed With SEC on May 6, 2021)
Agreement and Plan of Merger, dated as of April 27, 2021, by and among the Company, Merger Sub and Clarus (Filed With SEC on May 3, 2021)
Form of Common Stock Warrant (Filed With SEC on December 7, 2021)
Form of Pre-Funded Warrant (Filed With SEC on December 7, 2021)
Securities Purchase Agreement, dated as of December 3, 2021, among Clarus Therapeutics Holdings, Inc. and each purchaser party thereto (Filed With SEC on December 7, 2021)
Clarus Therapeutics Holdings, Inc. Employee Stock Purchase Plan (Filed With SEC on September 30, 2021)
Supplemental Indenture No. 3 between Clarus Therapeutics, Inc. and U.S. Bank National Association, dated as of September 28, 2021 (Filed With SEC on September 29, 2021)
Employment Agreement, dated September 9, 2021, by and between Clarus Therapeutics, Inc. and Robert E. Dudley (Filed With SEC on September 15, 2021)
Registration Rights Agreement, dated September 9, 2021, by and among the Company, Blue Water Sponsor LLC and Legacy Clarus securityholders party thereto (Filed With SEC on September 15, 2021)
Form of Indemnification Agreement (Officers) (Filed With SEC on September 15, 2021)
Employment Agreement, dated September 9, 2021, by and between Clarus Therapeutics, Inc. and Steven A. Bourne (Filed With SEC on September 15, 2021)
Employment Agreement, dated September 9, 2021, by and between Clarus Therapeutics, Inc. and Richard Peterson (Filed With SEC on September 15, 2021)
Employment Agreement, dated September 9, 2021, by and between Clarus Therapeutics, Inc. and Frank Jaeger (Filed With SEC on September 15, 2021)
Forms of Award Agreements under the 2021 Stock Option and Incentive Plan (Filed With SEC on September 15, 2021)
Supplemental Indenture No. 2, dated September 9, 2021 by and between Clarus Therapeutics, Inc. and U.S. Bank National Association (Filed With SEC on September 15, 2021)
Support Agreement, dated as of April 27, 2021, by and among the Company, Clarus and the Sponsor (Filed With SEC on May 3, 2021)
Transaction Support Agreement, dated of April 27, 2021 by and among the Company, Clarus and the Clarus securityholders party thereto (Filed With SEC on May 3, 2021)
Form of Registration Rights Agreement by and among the Company, the Sponsor and the Clarus securityholders party thereto (Filed With SEC on May 3, 2021)
Form of Lender Lock-Up Agreement by and between the Company and the noteholder of Clarus party thereto (Filed With SEC on May 3, 2021)
Form of Stockholder Lock-Up Agreement by and between the Company and the stockholder of Clarus party thereto (Filed With SEC on May 3, 2021)
Form of Support Agreement, dated as of April 27, 2021, by and among the Company, Clarus and the stockholder of Clarus party thereto (Filed With SEC on May 3, 2021)
Amendment, dated as of April 27, 2021, to Underwriting Agreement, dated as of December 15, 2020, by and between the Company and Maxim Group LLC (Filed With SEC on May 3, 2021)
Private Placement Warrant Purchase Agreement, dated December 15, 2020, by and between the Company and the Sponsor (Filed With SEC on December 21, 2020)
Services Agreement, dated December 15, 2020, by and between the Company and the Sponsor (Filed With SEC on December 21, 2020)
Registration Rights Agreement, dated December 15, 2020, by and among the Company, the Sponsor and Maxim Group LLC (Filed With SEC on December 21, 2020)
Investment Management Trust Agreement, dated December 15, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on December 21, 2020)
Letter Agreement, dated December 15, 2020, by and among the Company and its officers, its directors and the Sponsor (Filed With SEC on December 21, 2020)
Warrant Agreement, dated December 15, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on December 21, 2020)
Underwriting Agreement, dated December 15, 2020, by and among the Company and Maxim Group LLC (Filed With SEC on December 21, 2020)
Form of Indemnity Agreement (Filed With SEC on November 30, 2020)
Amended and Restated Promissory Note, dated October 20, 2020, issued to Joseph Hernandez (Filed With SEC on November 30, 2020)
Specimen Class A Common Stock Certificate (Filed With SEC on November 30, 2020)
Specimen Warrant Certificate (Filed With SEC on November 30, 2020)
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on November 30, 2020)
Form of Administrative Services Agreement between the Registrant and the Sponsor (Filed With SEC on November 30, 2020)
Form of Letter Agreement among the Registrant and its officers and directors and Blue Water Sponsor LLC (Filed With SEC on November 30, 2020)
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on November 30, 2020)
Form of Registration Rights Agreement among the Registrant and certain security holders (Filed With SEC on November 30, 2020)
Form of Private Placement Warrant Purchase Agreement between the Registrant and Blue Water Sponsor LLC (Filed With SEC on November 30, 2020)
Form of Underwriting Agreement (Filed With SEC on November 30, 2020)
Specimen Unit Certificate (Filed With SEC on November 30, 2020)
Securities Subscription Agreement, dated June 30, 2020, between the Registrant and Blue Water Sponsor LLC (Filed With SEC on September 3, 2020)
Promissory Note, dated June 30, 2020, issued to Joseph Hernandez (Filed With SEC on September 3, 2020)